To advance the development of its delivery system technology, NovaLipids has entered into international R&D agreements with pharmaceutical companies and academic institutions. The Company will continue to negotiate a variety of agreements, partnerships and collaborations with researchers, academic institutions and pharmaceutical and biotechnology companies in order to expand its product portfolio and market presence.